Skip to content

Valuable Connections: Dr Saskia Venne

Dortmund, 25th October 2024

The exchange of ideas, data and methods across disciplines and national borders is crucial for scientific progress. At ISAS, employees from all over the world therefore collaborate on interdisciplinary research. Not only do the diverse perspectives and experiences of the employees enable innovative research approaches, they also form the foundation for all kinds of internal cooperation as well as external, national and global partnerships.

Former researchers remain an integral part of the ISAS network. Whether they are now working in industry, at universities or in other research institutions - through ongoing exchange and close collaboration with the Institute, they contribute to the transfer of scientific findings from ISAS to their own fields. These networks are often the starting signal for new cooperations. In the coming weeks and months, former and current employees will report here on ISAS Kompakt on how their work at the institute and the experiences they gained in Dortmund have shaped their future careers or why their path led them to ISAS.

First up is Dr Saskia Venne. She completed her doctorate at ISAS from 2012 to 2016 and is now Team Leader Scientific Monitoring Bioanalysis in the Development NCE (New Chemical Entity) department at Boehringer Ingelheim Pharma. She told the editorial team the reasons for her decision to do her doctorate at ISAS and why researchers in industry benefit from experience at non-university research institutions.

Why did you make the decision in 2012 to pursue your PhD at ISAS?

Venne: It was important to me to gain experience outside of university, because I was looking for more international and cross-functional cooperation, for instance with hospitals or other non-university institutions. The Leibniz Network seemed to me to be a good starting point and ISAS offered a very impressive portfolio of state-of-the-art technologies.

Dr. Saskia Venne im Portrait.

© Boehringer Ingelheim Pharma

What did your research focus on during your time at ISAS?

Venne: The title of my PhD was “Characterisation of the Interaction of Post-translational Modification by means of Mass Spectrometry-based Proteome Research”. You can envisage this as the cell attempting to use post-translational modifications to react to external influences or disease to maintain homeostasis. By throwing light on these modulations, the hope is to obtain a better understanding of these processes and, ideally, also new approaches for treatment. So I established a method with which it was possible to determine three specific post-translational modifications in proteins. We then deployed these in various cooperation projects.

Did you benefit personally in any way from your time at the Institute?

Venne: Yes, of course, doing independent scientific work and independently driving forward a project. This means maintaining a high level of self-motivation over a long period of time, not being disheartened by failed attempts and trying again with a different approach. And lastly, I learnt that a well-maintained network is always a benefit and can open up many new opportunities.

Was the experience you gained from ISAS cooperation arrangements with hospitals useful for your ongoing professional career?

Venne: It was a great opportunity to learn how to interact with cooperation partners in a professional manner and to develop a sense for the ways in which the interests, approaches and issues may vary between different partners. Understanding other people’s position and striving to ultimately achieve a good result for all involved is a valuable characteristic for all later positions, especially for leadership positions.

Would you advise young researchers to become acquainted with scientific work at a non-university research institution before switching to industrial research?

Venne: Yes, definitely. Firstly, doctoral or postdoctoral positions are still few and far between in the industrial sector. Secondly, the scientific supervision and the environment at a non-university research institution are significantly more intense. It is worthwhile to gain initial experience here with other doctoral candidates and a PhD supervisor, and in a scientific environment, to work out where you as an individual want to go, what you like and to hone your own scientific expertise. In the industrial sector, you are often hired as an expert for a specific area and afterwards there may be very little help or opportunities for discussion - a solidly based scientific profile and a good network are extremely helpful in this respect.

Share

Further articles

3 Questions for Neele Rottmann

In the lab, Neele Rottmann prepares human and animal samples for mass spectrometry analysis. As part of the HI-FIVE project, she is helping to identify changes at the protein level in heart failure. Why does she spend so much time in the lab working on separations? The technical assistant shares the answer in this interview.

Neele Rottmann is wearing a white lab coat and purple gloves and is operating a mass spectrometry analyser in a laboratory. Next to her is a liquid chromatography system connected to a mass spectrometer via several tubes. There are numerous sample vials on the instrument. As she places a sample into the system, she looks into the camera.

High-tech against Cardiovascular Diseases: 3D Images of Blood Vessels

How do atherosclerotic plaques form in the coronary arteries? At ISAS, researchers are investigating cellular changes in human coronary arteries using techniques such as 3D imaging. During her internship, early-career researcher Leonie Menzel used a light sheet fluorescence microscope to analyse the spatial distribution of individual cells within the tissue. She thereby gained valuable methodological experience for her Master’s thesis.

3 Questions for Lukas Fu

How can AI support the analysis of biomedical images? This was the question Lukas Fu explored during his school internship at ISAS. The 15-year-old also successfully completed his first programming project.

Lukas Fu, a 15-year-old with short black hair. He is wearing glasses and is sitting on a low wall.

Separating Fluorescence Signals Faster and More Precisely with AI

When different fluorescence signals overlap during microscopy, their clear assignment to specific biological structures becomes difficult. To address this common problem, Dr Davide Panzeri is developing AI-based signal separation methods. The biophysicist has been awarded a Marie Skłodowska-Curie Fellowship by the European Union for his promising research project.

Porträt Dr. Davide Panzeri.

Passionate Research, Shaping the Future

How do GRK5 inhibitors work at the cellular level and within the living organism? Biologist Dr Susanne Grund is working with her colleagues at HI-FIVE on a new therapeutic approach for heart failure. In this portrait, she describes what her day-to-day work looks like, balancing research on human stem cells with studies on mice.

ISAS BFF Uploader

What are you doing at ISAS, Theresa?

Why do mice undergo ultrasound examinations of their hearts? What does a typical working day in the lab involve for a technical assistant in the HI-FIVE research project ? And what challenges does the job present? Theresa Pietz provides fascinating insights into her duties, motivations and experiences working with animals.

Study with Heart: A Doctor Bridging Clinic & Laboratory

What is actually happening behind the scenes of a patient trial? Anna Ruzhyna is a clinical research associate who looks after participants with heart failure as part of the HI-FIVE project. She explains how her work helps to develop new therapeutic approaches for the treatment of heart failure.

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.